tldrdaily.news logo
Tag

Drug Manufacturers

All articles tagged with #drug manufacturers

health2 years ago

RSV Vaccination Efforts Intensify with Increased Supply and Public Pressure

The Biden administration has secured a deal with drug manufacturers to make an additional 230,000 doses of the respiratory syncytial virus (RSV) shot available for infants by January, addressing a widespread shortage that has caused frustration among parents and pediatricians. The administration has been pressuring manufacturers to ramp up supply, with top officials engaging in high-level meetings to ensure that the shortfall doesn't become severe. The shortage has raised concerns about the availability of RSV shots as the RSV season peaks. The administration's efforts to boost supply come as the rollout of RSV shots serves as a test for post-Covid public health initiatives.

via POLITICO|
#biden-administration#drug-manufacturers#health
legalhealthcare2 years ago

Michigan Senate Takes Action on Auto Insurance and Drug Laws

Michigan residents may soon have the ability to sue drug manufacturers and sellers for harm caused by FDA-approved pharmaceutical drugs, thanks to a bill passed by the Michigan Senate. For the past 28 years, Michigan has had immunity protections for pharmaceutical companies, preventing residents from seeking legal recourse or financial compensation. The bill, which received bipartisan support, aims to remove this immunity and allow residents to hold companies accountable. Michigan's strong corporate liability shield has resulted in the state missing out on potential payouts from major pharma litigation cases. However, it is unlikely that residents will be able to retroactively receive compensation for missed opportunities. The Michigan Chamber of Commerce opposes the bill, while pharmaceutical researchers argue that it would burden the industry with greater liability costs. The bill now moves to the Michigan House.

via UpNorthLive.com|
#drug-manufacturers#immunity-protection#lawsuits
healthcare2 years ago

"Medicare's Potential Price Controls on Medications"

Medicare will directly set the prices of covered prescription drugs for the first time in history as part of the Inflation Reduction Act. The Centers for Medicare & Medicaid Services (CMS) plans to publish the list of the first 10 drugs subject to price controls in September. Some drug manufacturers, including Merck, Johnson & Johnson's Janssen Pharmaceuticals, and Bristol Myers Squibb, have disclosed that their medications, such as Januvia, Xarelto, Eliquis, and Opdivo, will be subject to controlled prices. This move has been met with opposition from some drug companies, who have sued the federal government over the program.

via Fox Business|
#drug-manufacturers#healthcare#inflation-reduction-act
health2 years ago

Lawsuit Targets Ozempic and Mounjaro Manufacturers for Stomach Paralysis Risk

Novo Nordisk and Eli Lilly, the manufacturers of weight loss drugs Ozempic and Mounjaro, are being sued by a Louisiana woman who claims they failed to warn patients about the risk of severe gastrointestinal problems, including gastroparesis (stomach paralysis) and gastroenteritis (stomach inflammation). The lawsuit alleges that the drug makers downplayed the severity of these side effects and accuses them of ignoring and not disclosing the association between the medications and gastrointestinal issues. The plaintiff suffered from severe vomiting, stomach pain, and other complications, resulting in hospitalization and permanent injuries. Ozempic and Mounjaro, originally developed for managing blood sugar levels in Type 2 diabetes patients, have gained popularity for off-label use in weight loss.

via KCAU 9|
#drug-manufacturers#gastrointestinal-problems#health
health2 years ago

Opioid Lawsuits Result in Billions in Settlements for Governments and States

Drug manufacturers Allergan and Teva, plus CVS, Walgreens, and Walmart will pay an additional $18.75 billion to settle lawsuits over their roles in the opioid crisis. The settlements will be paid to states and local governments to help communities still grappling with addiction and overdose. The distribution of funds will be calculated by population adjusted for the impact of the crisis. At least 85% of the money must go toward abating the drug crisis, and the companies are required to change their practices to protect the public. The national litigation remains ongoing with other defendants.

via The Washington Post|
#drug-manufacturers#health#lawsuits